Gerald Batist
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- COVID-19 and healthcare impacts
- Drug Transport and Resistance Mechanisms
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 109
- Colorectal Cancer Treatments and Studies 24
- Cancer Treatment and Pharmacology 19
-
- Cancer Genomics and Diagnostics 31
- Co-authors
- Charles Edwin Myers (9 shared papers)Kenneth H. Cowan (5 shared papers)Birandra Kumar Sinha (5 shared papers)Aspandiar G. Katki (8 shared papers)Moulay A. Alaoui‐Jamali (28 shared papers)Anil Tulpule (3 shared papers)Weimin Miao (6 shared papers)Mustapha Kandouz (12 shared papers)
- Journals
- Annals of Oncology (12 papers)Biochemical Pharmacology (12 papers)Journal of Clinical Oncology (11 papers)Critical Reviews in Oncology/Hematology (7 papers)Cancer Chemotherapy and Pharmacology (7 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Gerald Batist
315 papers receiving 16.2k citations
Gerald Batist's Hit Papers
Peers
Comparison fields: 5 of 179
- Oncology 5.9k
- Cancer Research 1.9k
- Geriatrics and Gerontology 341
- Molecular Biology 5.8k
- Biochemistry 552
Countries citing papers authored by Gerald Batist
This map shows the geographic impact of Gerald Batist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Batist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Batist more than expected).
Fields of papers citing papers by Gerald Batist
This network shows the impact of papers produced by Gerald Batist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Batist. The network helps show where Gerald Batist may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerald Batist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 324 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Hit paper breakdown → | 2020 | 1331 |
| 2 | Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study Hit paper breakdown → | 2001 | 954 |
| 3 | Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions Hit paper breakdown → | 2016 | 936 |
| 4 | Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. Hit paper breakdown → | 1986 | 752 |
| 5 | 2013 | 568 | |
| 6 | Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer Hit paper breakdown → | 2001 | 564 |
| 7 | Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion Hit paper breakdown → | 1985 | 513 |
| 8 | 2005 | 461 | |
| 9 | Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial Hit paper breakdown → | 2019 | 437 |
| 10 | 2001 | 433 | |
| 11 | The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Hit paper breakdown → | 2020 | 297 |
| 12 | 1986 | 270 | |
| 13 | 2000 | 209 | |
| 14 | 1987 | 203 | |
| 15 | 2021 | 197 | |
| 16 | 2013 | 192 | |
| 17 | 2009 | 189 | |
| 18 | 2002 | 185 | |
| 19 | Deficiency of connexin43 gap junctions is an independent marker for breast tumors. | 1999 | 173 |
| 20 | Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy. | 2003 | 160 |
About Gerald Batist
Gerald Batist is a scholar working on Oncology, Cancer Research, Molecular Biology, Biochemistry and Pulmonary and Respiratory Medicine, having authored 324 papers that have together received 16.9k indexed citations. Recurring topics across this work include Glutathione Transferases and Polymorphisms (37 papers), Cancer Genomics and Diagnostics (31 papers), Genomics, phytochemicals, and oxidative stress (28 papers), Colorectal Cancer Treatments and Studies (24 papers), Lung Cancer Treatments and Mutations (22 papers), Sulfur Compounds in Biology (20 papers), Cancer Treatment and Pharmacology (19 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). The work is most often cited by research in Oncology (5.9k citations), Cancer Research (1.9k citations), Geriatrics and Gerontology (341 citations), Molecular Biology (5.8k citations) and Biochemistry (552 citations). Gerald Batist has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Charles Edwin Myers, Kenneth H. Cowan, Birandra Kumar Sinha, Aspandiar G. Katki, Moulay A. Alaoui‐Jamali, Anil Tulpule, Weimin Miao, Mustapha Kandouz, P. James Scrivens and Lauri Welles. Their work appears in journals such as Annals of Oncology, Biochemical Pharmacology, Journal of Clinical Oncology, Critical Reviews in Oncology/Hematology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.